Description
LEVOMEXA-M contains Montelukast Sodium 4 mg and Levocetirizine Hydrochloride 2.5 mg in an oral suspension formulation. The combination provides leukotriene receptor antagonist and antihistamine activity and may be prescribed for the management of allergic symptoms and related respiratory conditions when clinically appropriate.
LEVOMEXA-M is supplied in a 60 ML pack with cap and carton.
For related formulations and therapeutic segments, explore the Medhexa Pharma Products range for additional allergy and respiratory-care formulations.
Therapeutic Segment
Anti-Allergic | Respiratory Care | Antihistamine | Leukotriene Receptor Antagonist | Oral Suspension
Uses of LEVOMEXA-M
LEVOMEXA-M combines Montelukast Sodium with Levocetirizine Hydrochloride to provide symptomatic support for allergic conditions.
It may be prescribed for:
- Allergic rhinitis
- Sneezing associated with allergies
- Runny or blocked nose
- Nasal itching
- Allergy-related watery or itchy eyes
- Other allergic symptoms when recommended by a healthcare professional
Montelukast is used for asthma and allergic rhinitis, while levocetirizine is an antihistamine used to relieve allergy symptoms. The exact use of this combination should follow the approved product information and healthcare professional’s advice.
Key Benefits of LEVOMEXA-M
- Combines Montelukast Sodium 4 mg + Levocetirizine Hydrochloride 2.5 mg
- Provides antihistamine activity through levocetirizine
- Helps control allergy-related nasal symptoms
- Supports relief from sneezing, runny nose and nasal itching
- Montelukast provides leukotriene receptor blocking activity
- Convenient oral suspension formulation
- Supplied in a 60 ML pack with cap and carton
How LEVOMEXA-M Works
LEVOMEXA-M contains two medicines that work through different pathways.
Montelukast blocks leukotriene receptors. Leukotrienes are inflammatory mediators involved in airway inflammation and allergic symptoms. By blocking these receptors, montelukast can help control certain asthma and allergy-related symptoms.
Levocetirizine is an antihistamine that reduces the effects of histamine, a substance involved in allergic reactions. This helps relieve symptoms such as sneezing, itching and runny nose.
Common Side Effects of LEVOMEXA-M
Possible side effects can vary between individuals. Depending on the ingredients, they may include:
- Headache
- Drowsiness or sleepiness
- Dry mouth
- Fatigue
- Abdominal discomfort
- Nausea
Levocetirizine may cause drowsiness in some patients. Therefore, caregivers should observe how the child responds to the medicine.
Montelukast also carries an important warning regarding neuropsychiatric effects, including changes in behaviour or mood and sleep-related symptoms.
Important Safety Information
- Use LEVOMEXA-M only according to the product label or as directed by a healthcare professional.
- Montelukast carries an FDA Boxed Warning for serious neuropsychiatric events. These reported events include agitation, aggression, depression, abnormal dreams, anxiety, hallucinations, sleep problems and suicidal thoughts or behaviour.
- Parents and caregivers should watch for new or unusual changes in behaviour, mood or sleep.
- If significant behavioural or mood changes, suicidal thoughts or other serious neuropsychiatric symptoms occur, stop montelukast-containing treatment and contact a healthcare professional immediately.
- For allergic rhinitis, FDA recommends reserving montelukast for patients who do not respond adequately to or cannot tolerate alternative treatments.
- Levocetirizine may cause drowsiness in some patients.
- Avoid combining with other antihistamines unless advised by a healthcare professional.
- Tell your doctor about other medicines the patient is taking.
- Use extra caution in patients with kidney problems because levocetirizine is primarily eliminated through the kidneys.
- Do not exceed the prescribed dose.
- Keep out of reach of children.
- Seek medical advice if allergic symptoms persist or worsen.
For detailed information about the montelukast safety warning, refer to the FDA Montelukast Drug Safety Communication.
Dosage & Administration
Use LEVOMEXA-M only according to the dosage prescribed by a healthcare professional or stated on the approved product label.
The appropriate dose can depend on the patient’s age, indication, clinical condition and kidney function. Do not determine the dose from the 60 ML bottle size.
Shake the suspension well before administration and measure each dose using the supplied measuring device.
Do not give a larger or more frequent dose than recommended.
Storage
Store LEVOMEXA-M according to the manufacturer’s labelled storage conditions.
- Keep the bottle tightly closed.
- Store away from excessive heat, moisture and direct sunlight.
- Keep in the original carton where appropriate.
- Keep out of reach of children.
- Check the product label for the exact storage temperature and expiry information.
